In AD, the blockade of the P2X7-ATP axis may be a potential target to prevent NLRP3 inflammasome final activation, IL-1β release, and consequent neuroinflammation (Thawkar and Kaur, 2019). Here, P2RX7 is linked to Alzheimer disease.